Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2021 · 10-Q
Revenue$24.83M$24.83M−4.5% vs Q2 2020 Net Income$820.00K$820.00K−80.2% vs Q2 2020 EPS Diluted$0.04$0.04−78.9% vs Q2 2020 Gross Profit$15,050,000−5.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$6,163,000+66.3% Free Cash Flowderived$5,967,000+67.9% Margins · derivedGross margin60.6%−0.9 pt vs Q2 2020
Operating margin2.8%−14.5 pt vs Q2 2020
Net margin3.3%−12.6 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end